Xenon Pharmaceuticals Inc. (XENE)
NASDAQ
Xenon Pharmaceuticals Inc. Total Liabilities 2012–2025
Xenon Pharmaceuticals Inc. annual total liabilities history from 2013 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Xenon Pharmaceuticals Inc. total liabilities as of December 31, 2025: 51.4M, a 18.89% increase year-over-year.
- Xenon Pharmaceuticals Inc. total liabilities for 2025 were 51.4M, a 18.89% increase from 2024.
- Xenon Pharmaceuticals Inc. total liabilities for 2024 were 43.2M, a 17.24% increase from 2023.
- Xenon Pharmaceuticals Inc. total liabilities for 2023 were 36.9M, a 12.95% increase from 2022.
- Xenon Pharmaceuticals Inc. total liabilities for 2022 were 32.6M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Xenon Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $51 |
| 2024 | $43 |
| 2023 | $37 |
| 2022 | $33 |
| 2021 | $22 |
| 2020 | $18 |
| 2019 | $56 |
| 2017 | $10 |
| 2016 | $4 |
| 2015 | $3 |
| 2014 | $15 |
| 2013 | $30 |
Xenon Pharmaceuticals Inc. Total Liabilities — FAQ
Xenon Pharmaceuticals Inc. (XENE) total liabilities over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XENE's total liabilities history?
The chart and table above show Xenon Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.